Galectin Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.80

-0.03 (-1.06%)

As of Feb 8, 2:06 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +362.9% upside

Low Target $9.51

Average Target $12.96

High Target $17.52

Current Price $2.80

Current
$2.80

Target
$12.96

$9.51 $12.96 avg $17.52

Scenario Analysis

Bear Case

$9.51

239.6%

Low target

Base Case

$12.96

+362.9%

Avg target

Bull Case

$17.52

+525.7%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$14.12

-80.2% from high

52-Week Low

$6.33

+-55.8% from low

Target vs 52W High

$12.96

-8.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%